APO-2L receptor agonist and CPT-11 synergism

Details for Australian Patent Application No. 2010202871 (hide)

Owner Genentech, Inc.

Inventors Escandon, Enrique; Fox, Judith A.; Kelley, Sean K.; Xiang, Hong

Agent Griffith Hack

Pub. Number AU-A-2010202871

Parent 2007201979

Filing date 7 July 2010

Wipo publication date 29 July 2010

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/4745 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

22 July 2010 Complete Application Filed

29 July 2010 Application Open to Public Inspection

  Published as AU-A-2010202871

24 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010202872-Weld analysis device and method

2010202870-Adaptive sleeve retainer for tool pick